Growing Demand from Pharma & Healthcare Sectors Will Strengthen the Aseptic Packaging Market in Americas by 2019
Heightened demand from the pharma and healthcare sectors is driving growth in the Aseptic Packaging Market in Americas, which is expected to grow at a CAGR of 9.37% from 2014 to 2019, says research firm TechNavio.
About the Report
Ensuring the safety of drugs before they are administered to patients has become one of the key concerns for health care providers. Adoption of the aseptic filling process guarantees an elongated shelf life for drugs at a much lower cost.
“The majority of demand for aseptic packaging from the pharmaceutical and healthcare sectors stems from the US, which alone accounted for more than 30% of the global market in 2014,” says Faisal Ghaus, Vice President of TechNavio.
Key Information Covered in the Report:
• Market segmentation, size and forecast through 2019
• Market Growth Drivers:
• Increased Focus on Product Innovation
• Market Challenges:
• Increased Concern over Contamination in Aseptic Packaging
• Market Trends:
• Adoption of Electrical Sterilization Methods for Solid Food Products
• Key Vendors:
• Amcor Ltd.
• Bemis Company Inc.
• Sealed Air Corp.
• Other Prominent Vendors:
• Aseptic Solutions USA
• CDF
• DS Smith
• Goglio
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.